FindTrial
Sign In

Prevention effect of low dose proton pump inhibitor for nonvariceal upper gastrointestinal bleeding in Chronic kidney disease in patients taking aspirin.

Primary prevention effect of low dose proton pump inhibitor for nonvariceal upper gastrointestinal bleeding in Chronic kidney disease or End stage renal disease in patients taking aspirin.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000814
Enrollment
400
Registered
2013-08-12
Start date
2013-06-28
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hallym University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. chronic kidney disease stage with eGFR < 60 ml/min/1.73m2 or end stage renal disease 2. the patients taking low dose aspirin (325mg or less per day)

Exclusion criteria

Exclusion criteria: 1. Concomitant use of H2 receptor blocker, anticoagulant agents or corticosteroids 2. A history of peptic ulcer disease, gastric surgery, chronic liver disease 3. A history of malignancy including stomach

Design outcomes

Primary

MeasureTime frame
hematemesis, melena, hematochezia, hemoglobin—

Secondary

MeasureTime frame
Systolic blood pressure;packed red blood cells;endoscopic finnding,;endoscopioc bleeding control procedure;operation;mortality—

Countries

Korea, Republic of

Contacts

Public ContactSuhee Song

Hallym University Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026